Abstract
Curcumin has numerous health benefits but has low bioavailability in the digestive system due to its low aqueous solubility, high metabolism rate caused by bile (from the liver), and degradation of curcumin under the basic conditions of the small intestine. The alternative way of delivering curcumin into the systemic circulation is through the buccal mucosa, but curcumin has to be delivered quickly before it undergoes degradation under the neutral conditions of the mouth. Oral disintegrating films (ODFs) are investigated as a pathway to release nanoparticles across the buccal mucosa to improve bioavailability. Chitosan, a mucoadhesive polymer, is used to coat nanoparticles. Pregelatinized starch (PGS), granular hydroxypropyl starch (GHS), hydroxypropylmethylcellulose (HPMC) and polyvinyl alcohol (PVA) are mucoadhesive polymers used in films, and propylene glycol (PG) as plasticizer. Mass, thickness, percentage recovery, surface pH, disintegration time and dissolution are assessed for each film. All films have a surface pH of around 6.7, making them non-irritant. Films with formulation of GHS and HPMC has highest maximum percentage dissolution, and has high percentage recovery, giving high drug load. It has released more curcumin than other films in the same time frame, allowing for curcumin to be released quickly. The average disintegration time for it is 53 minutes, which is long for ODFs. More drug can be released across the buccal mucosa over a longer timeframe. Films with PVA may be the thinnest and lightest, but break upon handling, making them hard to apply onto the buccal mucosa and unsuitable as an oral film.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adahoun, M. A., Al-Akhras, M. H., Jaafar, M. S., & Bououdina, M. (2016). Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artificial Cells, Nanomedicine, and Biotechnology, 45(1), 98–107.
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006). Multiple biological activities of curcumin: A short review. Life Sciences, 78(18), 2081–2087.
Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Letters, 223(2), 181–190.
Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research, 23, 363–398.
Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006). Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer, 106, 2503–2513.
Lev-Ari, S., Zinger, H., Kazanov, D., Yona, D., Ben-Yosef, R., Starr, A., et al. (2005). Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomedicine and Pharmacotherapy, 59(Suppl 2), S276–280.
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso- Ramos, C. E., et al. (2005). Curcumin suppresses the Paclitaxel induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clinical Cancer Research, 11, 7490–7498.
Khor, T. O., Keum, Y. S., Lin, W., Kim, J. H., Hu, R., Shen, G., et al. (2006). Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Research, 66, 613–621.
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., et al. (2007). Polymeric nanoparticle-encapsulated curcumin (‘nanocurcumin’): A novel strategy for human cancer therapy. Journal of Nanobiotechnology, 5, 3.
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., et al. (2004). Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Molecular Cancer Therapeutics, 3, 803–812.
Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., et al. (2005). Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical Cancer Research, 11, 6738–6744.
Mahmood, K., Zia, K. M., Zuber, M., Nazli, Z., Rehman, S., & Zia, F. (2016). Enhancement of bioactivity and bioavailability of curcumin with chitosan based materials. Korean Journal of Chemical Engineering, 33(12), 3316–3329.
Liu, W., Zhai, Y., Heng, X., Che, F. Y., Chen, W., Sun, D., et al. (2016). Oral bioavailability of curcumin: Problems and advancements. Journal of Drug Targeting, 4(8), 694–702.
Rajalakshmi, R., Indira, Y., Aruna, U., Vinesha, V., Rupangada, V., & Krishna, S. B. (2014). Chitosan nanoparticles—An emerging trend in nanotechnology. International Journal of Drug Delivery, 6(3), 204–229.
Rajan, S. S., Pandian, A., & Palaniappan, T. (2016). Curcumin loaded in bovine serum albumin–chitosan derived nanoparticles for targeted drug delivery. Bulletin of Materials Science, 39(3), 811–817.
Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research, 23(1A), 363–398.
Hanif, M., & Zaman, M. (2017). Thiolation of arabinoxylan and its application in the fabrication of controlled release mucoadhesive oral films. DARU Journal of Pharmaceutical Sciences, 25(1), 6.
Patel, R., & Shah, D. (2015). Nanoparticles loaded sublingual film as an effective treatment of chemotherapy induced nausea and vomiting. International Journal of PharmTech Research, 8(10), 77–87.
Mazzarino, L., Borsali, R., & Lemos-Senna, E. (2014). Mucoadhesive films containing chitosan-coated nanoparticles: A new strategy for buccal curcumin release. Journal of Pharmaceutical Sciences, 103(11), 3764–3771. https://doi.org/10.1002/jps.24142.
Mašek, J., Lubasová, D., Lukáč, R., Turánek-Knotigová, P., Kulich, P., Plocková, J., et al. (2017). Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines. Journal of Controlled Release, 249, 183–195.
Laffleur, F., Schmelzle, F., Ganner, A., & Vanicek, S. (2016). In vitro and ex vivo evaluation of novel curcumin-loaded excipient for Buccal delivery. AAPS PharmSciTech.
Mazzarino, L., Coche-Guérente, L., Lemos-Senna, P. L., & Borsali, R. (2014). On the mucoadhesive properties of chitosan-coated polycaprolactone nanoparticles loaded with curcumin using quartz crystal microbalance with dissipation monitoring. Journal of Biomedical Nanotechnology, 10(5), 787–794.
Mazzarino, L., Travelet, C., Ortega-Murillo, S., Otsuka, I., Pignot-Paintrand, I., Lemos-Senna, E., et al. (2012). Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. Journal of Colloid and Interface Science, 370(1), 58–66.
Ramdayal, G., Suresh, P., & Kr, S. U. (2011). Comparative study on novel pregelatinized garadu starch PGGS and starch 1500 as a direct compression/wet-granulation tableting excipient. Journal of Pharmacy Research, 4, 2406–2410.
Muppalaneni, S., & Omidian, H. (2013). Polyvinyl alcohol in medicine and pharmacy: A perspective. Journal of Developing Drugs, 02(03). https://doi.org/10.4172/2329-6631.1000112.
Karki, S., Kim, H., Na, S., Shin, D., Jo, K., & Lee, J. (2016). Thin films as an emerging platform for drug delivery. Asian Journal of Pharmaceutical Sciences, 11(5), 559–574. Retrieved from https://doi.org/10.1016/j.ajps.2016.05.004.
Muralisrinivasan, N. S. (2017). Polymer blends and composites: Chemistry and technology. Hoboken, NJ: John Wiley & Sons Inc.
Okaya, T., Kohno, H., Terada, K., Sato, T., Maruyama, H., & Yamauchi, J. (1992). Specific interaction of starch and polyvinyl alcohols having long alkyl groups. Journal of Applied Polymer Science, 45(7), 1127–1134. https://doi.org/10.1002/app.1992.070450701.
Rane, S. S., Hamed, E., & Rieschl, S. (2012). An exact model for predicting tablet and blend content uniformity based on the theory of fluctuations in mixtures. Journal of Pharmaceutical Sciences, 101(12), 4501–4515. https://doi.org/10.1002/jps.23313.
Choi, D., & Hong, J. (2013). Layer-by-layer assembly of multilayer films for controlled drug release. Archives of Pharmacal Research, 37(1), 79–87. https://doi.org/10.1007/s12272-013-0289-x.
Lindert, S., & Breitkreutz, J. (2017). Oromucosal multilayer films for tailor-made, controlled drug delivery. Expert Opinion on Drug Delivery, 1–15. https://doi.org/10.1080/17425247.2017.1276899.
Choi, M., Kim, K., Heo, J., Jeong, H., Kim, S. Y., & Hong, J. (2015). Multilayered graphene nano-film for controlled protein delivery by desired electro-stimuli. Scientific Reports, 5(1). https://doi.org/10.1038/srep17631.
Acknowledgements
We thank Associate Professor Kunn Hadinoto Ong, Mr. William Phua, and Lim Li Ming for helping us throughout our project as our supervisor, teacher mentor and student mentor respectively.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Lim, B., Theng, M.W. (2019). Buccal Delivery of Curcumin to Address Its Poor Gastrointestinal Stability. In: Guo, H., Ren, H., Bandla, A. (eds) IRC-SET 2018. Springer, Singapore. https://doi.org/10.1007/978-981-32-9828-6_26
Download citation
DOI: https://doi.org/10.1007/978-981-32-9828-6_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9827-9
Online ISBN: 978-981-32-9828-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)